Columns

MS news notes: Tysabri biosimilar, diet, cognitive rehab, aging

Welcome to ā€œMS News Notes,ā€ a weekly Monday morning column where I comment on multiple sclerosis (MS) news stories that caught my eye last week. Hereā€™s a look at whatā€™s been happening: Tysabri biosimilar on the horizon Tysabri (natalizumab) is a very effective disease-modifying therapy (DMT) for…

A Primer on ABLE Accounts for Americans With Disabilities

Have you ever heard of an ABLE savings account? I hadn’t until a couple weeks ago. The acronym stands for the Achieving a Better Life Experience Act, a law passed by the U.S. Congress in 2014. It created special savings accounts that allow disabled Americans, including people with…

MS cognitive fog is the hardest symptom for me to accept

ā€œYou only begin to grasp the import of an event ā€“ and its larger implications vis-Ć -vis your life ā€“ long after it has entered into that realm marked ā€˜memory.’ā€ ā€” Douglas Kennedy, “The Moment“ I am reading my first book since multiple sclerosis (MS) fatigueĀ reared its…

MS News Notes: Tascenso ODT Approval, Baclofen Disdain, Myelin

Welcome to ā€œMS News Notes,ā€ where I comment on multiple sclerosis (MS) news stories that caught my eye last week. Hereā€™s a look at whatā€™s been happening: Gilenya alternative The disease-modifying therapy (DMT) Gilenya (fingolimod) has been around since 2010. Now the U.S. Food and Drug Administration has…

Could the Key to New MS Treatments Be in Outer Space?

As you read this, a group of scientists is doing multiple sclerosis (MS) research high above the earth. Their laboratory is in orbit about 250 miles up, aboard the International Space Station. Working with researchers at the New York Stem Cell Foundation (NYSCF), astronauts have been helping…

MS News Notes: COVID-19, Gut Bacteria, Remyelination, Stem Cells

Welcome to ā€œMS News Notes,ā€ where I comment on multiple sclerosis (MS) news stories that caught my eye last week. Hereā€™s a look at whatā€™s been happening: Could COVID-19 trigger MS? Since the start of the COVID-19 pandemic, there have been scattered reports of people who’ve developed neurological disorders,…

MS News Notes: PoNS Online, Foralumab, Masitinib, Gaslighting

Welcome to ā€œMS News Notes,ā€ where I comment on multiple sclerosis (MS) news stories that caught my eye last week. Hereā€™s a look at whatā€™s been happening: Tongue stimulator now easier to obtain A Portable Neuromodulation Stimulator (PoNS) is a mouthpiece that mildly stimulates nerves in the tongue that…

FDA Approval of Ublituximab, Now Briumvi, Is Good News

The new year is bringing a new disease-modifying therapy (DMT) to the multiple sclerosis (MS) arsenal. Shortly after Christmas, the U.S. Food and Drug Administration (FDA) approved Briumvi (ublituximab), which joins a small group of DMTs that aim to halt MS progression by knocking out certain…

This New Year, I Resolve to Let Myself Hope

The new year is just a few days away, so if you haven’t already, you might want to start thinking about resolutions, if you’re so inclined. Although I personally don’t bother these days, about half of American adults do, although that number is declining. One study suggests that…

I Am What I Am: Embracing the Highs and Lows of MS

If thereā€™s one thing those of us who have multiple sclerosis (MS) know all too well, itā€™s that life requires balance. Fellow columnists and I have written about the need to find a happy medium when it comes to mental, physical, and emotional well-being.

MS News Notes: Brain Stimulation, Bright Light, ABA-101, Foralumab

Welcome to ā€œMS News Notes,ā€ where I comment on multiple sclerosis (MS) news stories that caught my eye last week. Hereā€™s a look at whatā€™s been happening: Possible nonmedicinal treatment for fatigue, spasticity, pain Wouldn’t it be nice to find a treatment that helps people with MS handle three…

MS News Notes: DMT Costs, Copaxone, EBV, Rituximab

Welcome to ā€œMS News Notes,ā€ where I comment on multiple sclerosis (MS) news stories that caught my eye last week. Hereā€™s a look at whatā€™s been happening: Is cost a factor when deciding DMT use? Cost may be the elephant in the room when people with MS are…